Keyword: Institute of Biomedicine
This year, the Elias Tillandz prize for the best scientific paper published in 2019 in BioCity Turku has been awarded to Academician Sirpa Jalkanen and her research group.
Gut microbiota Not Involved in the Incidence of Gestational Diabetes Mellitus – But Gut Microbiota May Be Modulated by Fish Oil And Probiotics
Consuming the combination of fish oil and probiotic food supplements modulate the composition of gut microbiota in overweight and obese pregnant women, reveals a new study conducted at the University of Turku, Finland. The same study shows that gut microbiota composition and function is not related to gestational diabetes.
Despite of continuous development in breast cancer treatments, metastases of the most aggressive breast cancer types are still a significant and growing medical problem. Together with a research group at Michigan University, the group of Professor Jukka Westermarck at Turku Bioscience Centre recently received funding from the US Department of Defense for the development of novel treatment strategies for breast cancer metastases.
The virologists at the University of Turku have followed the spread of the novel SARS-CoV-2 virus closely since the beginning of the year. Laboratories in Turku received the first genes of the new virus in February and, ever since, researchers have strived to solve the mysteries of the pathogen only the size of 120 nanometres.
World leading diabetes research foundation JDRF from the United States has granted the University of Turku three-year funding for its PAMP project (Pathogen Associated Molecular Patterns) with the total sum of over €520,000.
Infectious disease scientists identified strains of group A streptococcus that are less susceptible to commonly used antibiotics, a sign that the germ causing strep throat and flesh-eating disease may be moving closer to resistance to penicillin and other related antibiotics known as beta-lactams.
Finnish researchers have identified an exonic variant in the TRIM55 gene, which affects cardiomyocyte specific functions and reduces cardiac contractility.
Researchers have discovered new changes in blood samples which are associated with Alzheimer’s disease. A new international study examined Finnish twins. The study was conducted on disease-discordant twin pairs: one sibling who suffered from Alzheimer’s disease and one who was cognitively healthy. The researchers utilised the latest genome-wide methods to find out whether the twins’ blood samples had any disease-related differences in chemical marks, so-called epigenetic marks, which are sensitive to changes in environmental and lifestyle factors.